177 related articles for article (PubMed ID: 32162034)
1. Pediatric low-grade gliomas: molecular characterization of patient-derived cellular models.
Chiacchiarini M; Besharat ZM; Carai A; Miele E; Del Baldo G; Mastronuzzi A; Catanzaro G; Ferretti E
Childs Nerv Syst; 2021 Mar; 37(3):771-778. PubMed ID: 32162034
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas.
Fukuoka K; Mamatjan Y; Tatevossian R; Zapotocky M; Ryall S; Stucklin AG; Bennett J; Nobre LF; Arnoldo A; Luu B; Wen J; Zhu K; Leon A; Torti D; Pugh TJ; Hazrati LN; Laperriere N; Drake J; Rutka JT; Dirks P; Kulkarni AV; Taylor MD; Bartels U; Huang A; Zadeh G; Aldape K; Ramaswamy V; Bouffet E; Snuderl M; Ellison D; Hawkins C; Tabori U
Neuro Oncol; 2020 Oct; 22(10):1474-1483. PubMed ID: 32242226
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.
Lassaletta A; Zapotocky M; Mistry M; Ramaswamy V; Honnorat M; Krishnatry R; Guerreiro Stucklin A; Zhukova N; Arnoldo A; Ryall S; Ling C; McKeown T; Loukides J; Cruz O; de Torres C; Ho CY; Packer RJ; Tatevossian R; Qaddoumi I; Harreld JH; Dalton JD; Mulcahy-Levy J; Foreman N; Karajannis MA; Wang S; Snuderl M; Nageswara Rao A; Giannini C; Kieran M; Ligon KL; Garre ML; Nozza P; Mascelli S; Raso A; Mueller S; Nicolaides T; Silva K; Perbet R; Vasiljevic A; Faure Conter C; Frappaz D; Leary S; Crane C; Chan A; Ng HK; Shi ZF; Mao Y; Finch E; Eisenstat D; Wilson B; Carret AS; Hauser P; Sumerauer D; Krskova L; Larouche V; Fleming A; Zelcer S; Jabado N; Rutka JT; Dirks P; Taylor MD; Chen S; Bartels U; Huang A; Ellison DW; Bouffet E; Hawkins C; Tabori U
J Clin Oncol; 2017 Sep; 35(25):2934-2941. PubMed ID: 28727518
[TBL] [Abstract][Full Text] [Related]
4. BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.
Mistry M; Zhukova N; Merico D; Rakopoulos P; Krishnatry R; Shago M; Stavropoulos J; Alon N; Pole JD; Ray PN; Navickiene V; Mangerel J; Remke M; Buczkowicz P; Ramaswamy V; Guerreiro Stucklin A; Li M; Young EJ; Zhang C; Castelo-Branco P; Bakry D; Laughlin S; Shlien A; Chan J; Ligon KL; Rutka JT; Dirks PB; Taylor MD; Greenberg M; Malkin D; Huang A; Bouffet E; Hawkins CE; Tabori U
J Clin Oncol; 2015 Mar; 33(9):1015-22. PubMed ID: 25667294
[TBL] [Abstract][Full Text] [Related]
5. Pediatric low-grade gliomas can be molecularly stratified for risk.
Yang RR; Aibaidula A; Wang WW; Chan AK; Shi ZF; Zhang ZY; Chan DTM; Poon WS; Liu XZ; Li WC; Zhang RQ; Li YX; Chung NY; Chen H; Wu J; Zhou L; Li KK; Ng HK
Acta Neuropathol; 2018 Oct; 136(4):641-655. PubMed ID: 29948154
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics and therapeutic targets of pediatric low-grade gliomas.
Tateishi K; Nakamura T; Yamamoto T
Brain Tumor Pathol; 2019 Apr; 36(2):74-83. PubMed ID: 30929113
[TBL] [Abstract][Full Text] [Related]
7. Retrospective and integrative analyses of molecular characteristics and their specific imaging parameters in pediatric grade 1 gliomas.
Coutant M; Lhermitte B; Guérin E; Chammas A; Reita D; Sebastia C; Douzal V; Gabor F; Salmon A; Chenard MP; Todeschi J; Coca A; Heng MA; Vincent F; Entz-Werlé N
Pediatr Blood Cancer; 2022 Aug; 69(8):e29575. PubMed ID: 35373885
[TBL] [Abstract][Full Text] [Related]
8. Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas.
Milde T; Rodriguez FJ; Barnholtz-Sloan JS; Patil N; Eberhart CG; Gutmann DH
Neuro Oncol; 2021 Oct; 23(10):1634-1646. PubMed ID: 34131743
[TBL] [Abstract][Full Text] [Related]
9. Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.
Bergthold G; Bandopadhayay P; Hoshida Y; Ramkissoon S; Ramkissoon L; Rich B; Maire CL; Paolella BR; Schumacher SE; Tabak B; Ferrer-Luna R; Ozek M; Sav A; Santagata S; Wen PY; Goumnerova LC; Ligon AH; Stiles C; Segal R; Golub T; Grill J; Ligon KL; Chan JA; Kieran MW; Beroukhim R
Neuro Oncol; 2015 Nov; 17(11):1486-96. PubMed ID: 25825052
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Pediatric Low-Grade Gliomas.
Sait SF; Giantini-Larsen AM; Tringale KR; Souweidane MM; Karajannis MA
Curr Neurol Neurosci Rep; 2023 Apr; 23(4):185-199. PubMed ID: 36881254
[TBL] [Abstract][Full Text] [Related]
11. The miR-139-5p regulates proliferation of supratentorial paediatric low-grade gliomas by targeting the PI3K/AKT/mTORC1 signalling.
Catanzaro G; Besharat ZM; Miele E; Chiacchiarini M; Po A; Carai A; Marras CE; Antonelli M; Badiali M; Raso A; Mascelli S; Schrimpf D; Stichel D; Tartaglia M; Capper D; von Deimling A; Giangaspero F; Mastronuzzi A; Locatelli F; Ferretti E
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):687-706. PubMed ID: 29478280
[TBL] [Abstract][Full Text] [Related]
12. A Molecular Update and Review of Current Trials in Paediatric Low-Grade Gliomas.
Al-Jilaihawi S; Lowis S
Pediatr Neurosurg; 2023; 58(5):290-298. PubMed ID: 37604126
[TBL] [Abstract][Full Text] [Related]
13. Unsupervised machine learning using K-means identifies radiomic subgroups of pediatric low-grade gliomas that correlate with key molecular markers.
Haldar D; Kazerooni AF; Arif S; Familiar A; Madhogarhia R; Khalili N; Bagheri S; Anderson H; Shaikh IS; Mahtabfar A; Kim MC; Tu W; Ware J; Vossough A; Davatzikos C; Storm PB; Resnick A; Nabavizadeh A
Neoplasia; 2023 Feb; 36():100869. PubMed ID: 36566592
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
[TBL] [Abstract][Full Text] [Related]
15. An integrative molecular and genomic analysis of pediatric hemispheric low-grade gliomas: an update.
Lassaletta A; Zapotocky M; Bouffet E; Hawkins C; Tabori U
Childs Nerv Syst; 2016 Oct; 32(10):1789-97. PubMed ID: 27659822
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular characteristics of pediatric low-grade glioma complicated with ventriculo-peritoneal shunt related ascites.
Solano-Páez P; Fonseca A; Baroni LV; Amayiri N; Somarriba MP; Freytes C; Quiroga E; Rivero M; Márquez J; Lassaletta Á; Bouffet E
J Neurooncol; 2022 Mar; 157(1):147-156. PubMed ID: 35122583
[TBL] [Abstract][Full Text] [Related]
17. BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas.
Olow A; Mueller S; Yang X; Hashizume R; Meyerowitz J; Weiss W; Resnick AC; Waanders AJ; Stalpers LJ; Berger MS; Gupta N; James CD; Petritsch CK; Haas-Kogan DA
Clin Cancer Res; 2016 Nov; 22(21):5312-5321. PubMed ID: 27217440
[TBL] [Abstract][Full Text] [Related]
18. Clinical management and genomic profiling of pediatric low-grade gliomas in Saudi Arabia.
Mobark NA; Alharbi M; Alhabeeb L; AlMubarak L; Alaljelaify R; AlSaeed M; Almutairi A; Alqubaishi F; Ahmad M; Al-Banyan A; Alotabi FE; Barakeh D; AlZahrani M; Al-Khalidi H; Ajlan A; Ramkissoon LA; Ramkissoon SH; Abedalthagafi M
PLoS One; 2020; 15(1):e0228356. PubMed ID: 31995621
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition.
Nobre L; Zapotocky M; Ramaswamy V; Ryall S; Bennett J; Alderete D; Balaguer Guill J; Baroni L; Bartels U; Bavle A; Bornhorst M; Boue DR; Canete A; Chintagumpala M; Coven SL; Cruz O; Dahiya S; Dirks P; Dunkel IJ; Eisenstat D; Faure Conter C; Finch E; Finlay JL; Frappaz D; Garre ML; Gauvain K; Bechensteen AG; Hansford JR; Harting I; Hauser P; Hazrati LN; Huang A; Injac SG; Iurilli V; Karajannis M; Kaur G; Kyncl M; Krskova L; Laperriere N; Larouche V; Lassaletta A; Leary S; Lin F; Mascelli S; McKeown T; Milde T; Morales La Madrid A; Morana G; Morse H; Mushtaq N; Osorio DS; Packer R; Pavelka Z; Quiroga-Cantero E; Rutka J; Sabel M; Salgado D; Solano P; Sterba J; Su J; Sumerauer D; Taylor MD; Toledano H; Tsang DS; Valente Fernandes M; van Landeghem F; van Tilburg CM; Wilson B; Witt O; Zamecnik J; Bouffet E; Hawkins C; Tabori U
JCO Precis Oncol; 2020; 4():. PubMed ID: 32923898
[TBL] [Abstract][Full Text] [Related]
20. CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles.
Jain P; Fierst TM; Han HJ; Smith TE; Vakil A; Storm PB; Resnick AC; Waanders AJ
Oncogene; 2017 Nov; 36(45):6348-6358. PubMed ID: 28806393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]